Cargando…

Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment

INTRODUCTION: Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairm...

Descripción completa

Detalles Bibliográficos
Autores principales: Padulo, Caterina, Sestieri, Carlo, Punzi, Miriam, Picerni, Eleonora, Chiacchiaretta, Piero, Tullo, Maria Giulia, Granzotto, Alberto, Baldassarre, Antonello, Onofrj, Marco, Ferretti, Antonio, Delli Pizzi, Stefano, Sensi, Stefano L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694338/
http://dx.doi.org/10.1002/trc2.12436
_version_ 1785153353980837888
author Padulo, Caterina
Sestieri, Carlo
Punzi, Miriam
Picerni, Eleonora
Chiacchiaretta, Piero
Tullo, Maria Giulia
Granzotto, Alberto
Baldassarre, Antonello
Onofrj, Marco
Ferretti, Antonio
Delli Pizzi, Stefano
Sensi, Stefano L.
author_facet Padulo, Caterina
Sestieri, Carlo
Punzi, Miriam
Picerni, Eleonora
Chiacchiaretta, Piero
Tullo, Maria Giulia
Granzotto, Alberto
Baldassarre, Antonello
Onofrj, Marco
Ferretti, Antonio
Delli Pizzi, Stefano
Sensi, Stefano L.
author_sort Padulo, Caterina
collection PubMed
description INTRODUCTION: Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). METHODS: Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow‐up: 75 who remained stable (s‐HC) and 22 who converted to MCI within 48 months (c‐HC). Anatomical magnetic resonance (MR) images were analyzed using a semi‐automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD‐related pathology, and the whole cortical thickness as a test of spatial specificity. RESULTS: Compared with s‐HC individuals, c‐HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro‐structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48‐month follow‐up), suggesting that amygdala changes shape the cognitive progression to MCI. DISCUSSION: Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. HIGHLIGHTS: Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI). Amygdala's was observed within the basolateral and amygdaloid complexes. Macro‐structural alterations were associated with cognitive decline. No atrophy was found in the hippocampus and cortex.
format Online
Article
Text
id pubmed-10694338
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106943382023-12-05 Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment Padulo, Caterina Sestieri, Carlo Punzi, Miriam Picerni, Eleonora Chiacchiaretta, Piero Tullo, Maria Giulia Granzotto, Alberto Baldassarre, Antonello Onofrj, Marco Ferretti, Antonio Delli Pizzi, Stefano Sensi, Stefano L. Alzheimers Dement (N Y) Research Articles INTRODUCTION: Accumulating evidence indicates that the amygdala exhibits early signs of Alzheimer's disease (AD) pathology. However, it is still unknown whether the atrophy of distinct subfields of the amygdala also participates in the transition from healthy cognition to mild cognitive impairment (MCI). METHODS: Our sample was derived from the AD Neuroimaging Initiative 3 and consisted of 97 cognitively healthy (HC) individuals, sorted into two groups based on their clinical follow‐up: 75 who remained stable (s‐HC) and 22 who converted to MCI within 48 months (c‐HC). Anatomical magnetic resonance (MR) images were analyzed using a semi‐automatic approach that combines probabilistic methods and a priori information from ex vivo MR images and histology to segment and obtain quantitative structural metrics for different amygdala subfields in each participant. Spearman's correlations were performed between MR measures and baseline and longitudinal neuropsychological measures. We also included anatomical measurements of the whole amygdala, the hippocampus, a key target of AD‐related pathology, and the whole cortical thickness as a test of spatial specificity. RESULTS: Compared with s‐HC individuals, c‐HC subjects showed a reduced right amygdala volume, whereas no significant difference was observed for hippocampal volumes or changes in cortical thickness. In the amygdala subfields, we observed selected atrophy patterns in the basolateral nuclear complex, anterior amygdala area, and transitional area. Macro‐structural alterations in these subfields correlated with variations of global indices of cognitive performance (measured at baseline and the 48‐month follow‐up), suggesting that amygdala changes shape the cognitive progression to MCI. DISCUSSION: Our results provide anatomical evidence for the early involvement of the amygdala in the preclinical stages of AD. HIGHLIGHTS: Amygdala's atrophy marks elderly progression to mild cognitive impairment (MCI). Amygdala's was observed within the basolateral and amygdaloid complexes. Macro‐structural alterations were associated with cognitive decline. No atrophy was found in the hippocampus and cortex. John Wiley and Sons Inc. 2023-12-03 /pmc/articles/PMC10694338/ http://dx.doi.org/10.1002/trc2.12436 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Padulo, Caterina
Sestieri, Carlo
Punzi, Miriam
Picerni, Eleonora
Chiacchiaretta, Piero
Tullo, Maria Giulia
Granzotto, Alberto
Baldassarre, Antonello
Onofrj, Marco
Ferretti, Antonio
Delli Pizzi, Stefano
Sensi, Stefano L.
Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title_full Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title_fullStr Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title_full_unstemmed Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title_short Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
title_sort atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694338/
http://dx.doi.org/10.1002/trc2.12436
work_keys_str_mv AT padulocaterina atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT sestiericarlo atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT punzimiriam atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT picernieleonora atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT chiacchiarettapiero atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT tullomariagiulia atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT granzottoalberto atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT baldassarreantonello atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT onofrjmarco atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT ferrettiantonio atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT dellipizzistefano atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT sensistefanol atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment
AT atrophyofspecificamygdalasubfieldsinsubjectsconvertingtomildcognitiveimpairment